Molecular genetic basis of antimicrobial agent resistance inMycobacterium tuberculosis: 1998 update
S Ramaswamy, JM Musser - Tubercle and Lung disease, 1998 - Elsevier
Knowledge of the molecular genetic basis of resistance to antituberculous agents has
advanced rapidly since we reviewed this topic 3 years ago. Virtually all isolates resistant to …
advanced rapidly since we reviewed this topic 3 years ago. Virtually all isolates resistant to …
Treatment of multidrug-resistant tuberculosis
MD Iseman - New England Journal of Medicine, 1993 - Mass Medical Soc
The era of modern, predictably effective tuberculosis chemotherapy began in 1952. Since
then, strains of Mycobacterium tuberculosis have acquired resistance to various drugs, thus …
then, strains of Mycobacterium tuberculosis have acquired resistance to various drugs, thus …
Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre …
Summary Background The Xpert MTB/RIF test (Cepheid, Sunnyvale, CA, USA) can detect
tuberculosis and its multidrug-resistant form with very high sensitivity and specificity in …
tuberculosis and its multidrug-resistant form with very high sensitivity and specificity in …
Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis
A Telenti, P Imboden, F Marchesi, L Matter, K Schopfer… - The Lancet, 1993 - Elsevier
Control of tuberculosis is threatened by widespread emergence of drug resistance in
Mycobacterium tuberculosis. Understanding the molecular basis of resistance might lead to …
Mycobacterium tuberculosis. Understanding the molecular basis of resistance might lead to …
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
CK Stover, P Warrener, DR VanDevanter, DR Sherman… - Nature, 2000 - nature.com
Mycobacterium tuberculosis, which causes tuberculosis, is the greatest single infectious
cause of mortality worldwide, killing roughly two million people annually. Estimates indicate …
cause of mortality worldwide, killing roughly two million people annually. Estimates indicate …
[图书][B] Evolution of infectious disease
PW Ewald - 1994 - books.google.com
Findings from the field of evolutionary biology are yielding dramatic insights for health
scientists, especially those involved in the fight against infectious diseases. This book is the …
scientists, especially those involved in the fight against infectious diseases. This book is the …
Antimicrobial agent resistance in mycobacteria: molecular genetic insights
JM Musser - Clinical microbiology reviews, 1995 - Am Soc Microbiol
The primary theme emerging from molecular genetic work conducted with Mycobacterium
tuberculosis and several other mycobacterial species is that resistance is commonly …
tuberculosis and several other mycobacterial species is that resistance is commonly …
Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations
The emergence of multidrug-resistant strains of Mycobacterium tuberculosis has resulted in
increased interest in the fluoroquinolones (FQs) as antituberculosis agents. To investigate …
increased interest in the fluoroquinolones (FQs) as antituberculosis agents. To investigate …
HIV-TB co-infection: epidemiology, diagnosis & management
SK Sharma, A Mohan… - Indian Journal of Medical …, 2005 - repository.ias.ac.in
HIV/AIDS pandemic has caused a resurgence of TB, resulting in increased morbidity and
mortality worldwide. HIV and Mycobacterium tuberculosis have a synergistic interaction; …
mortality worldwide. HIV and Mycobacterium tuberculosis have a synergistic interaction; …
Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin
M Goble, MD Iseman, LA Madsen… - New England journal …, 1993 - Mass Medical Soc
Background and Methods The frequency of infection with multidrug-resistant Mycobacterium
tuberculosis is increasing. We reviewed the clinical courses of 171 patients with pulmonary …
tuberculosis is increasing. We reviewed the clinical courses of 171 patients with pulmonary …